Cell Signaling Technology

Product Pathways - Growth Factors/Cytokines

Human His6IGFBP3 (hHis6IGFBP3) #12579

No. Size Price
12579LC 50 µg ( With Carrier ) ¥6,860.00 现货查询 购买询价
12579LF 50 µg ( Carrier Free ) ¥6,860.00 现货查询 购买询价
12579SC 10 µg ( With Carrier ) ¥2,321.00 现货查询 购买询价
12579SF 10 µg ( Carrier Free ) ¥2,321.00 现货查询 购买询价
12579 carrier free & custom formulation / quantityemail request
Applications Dilution Species-Reactivity Sensitivity MW (kDa) Isotype

Species cross-reactivity is determined by western blot.

Applications Key:

Source / Purification

Recombinant Human His6IGFBP3 (hHis6IGFBP3) Gly28-Lys291 (Accession #NP_17936) was expressed in human 293 cells at Cell Signaling Technology.

在人293细胞中表达重组人His6 IGFBP3 (hHis6IGFBP3) Gly28-Lys291 (Accession #NP_17936)。

Molecular Characterization

Recombinant N-terminally His6-tagged hIGFBP3 has a calculated MW of 30,7123 Da. DTT reduced and nonreduced protein migrate as 50 kDa polypeptides. Lower mobility and heterogeneity in SDS-PAGE are due to glycosylation. The expected amino terminus of recombinant hHis6IGFBP3 was verified by amino acid sequencing.

重组N端His标签的 hIGFBP3分子量30,7123 Da。DTT还原和非还原蛋白迁移大小为50 kDa。SDS-PAGE中低迁移率和均质性是由糖基化引起的。预测的重组hHis6IGFBP3的氨基端序列通过氨基酸测序确认。


>95% as determined by SDS-PAGE of 6 μg reduced (+) and nonreduced (-) recombinant hHisIGFBP3. All lots are greater than 95% pure.

通过SDS-PAGE确认6 μg还原(+)和未还原(-)重组hHisIGFBP3纯度大于>95%。所有的批次纯度都大于>95%。


The bioactivity of hHis6IGFBP3 was determined by inhibition of IGF-I induced AKT phosphorylation in human dermal fibroblasts. The ED50 of each lot is between 2.5-9 ng/ml.

hHis6IGFBP3的活性通过抑制人皮肤成纤维细胞中IGF- I诱导的AKT磷酸化而测定。



The inhibition of IGF-I induced Akt phosphorylation by hHis6IGFBP3. Human dermal fibroblasts were treated with Human Insulin-like Growth Factor I (hIGF-I) # 8917 in the presence or absence of increasing concentrations of hHis6IGFBP3 for 10 minutes, lysed, and Akt1 (Ser473) phosphorylation was quantified using the PathScan® Phospho-Akt1 (Ser473) Sandwich ELISA Kit #7160.

抑制IGF-I可以促进Akt被hHis6IGFBP3磷酸化。人皮肤成纤维细胞使用人胰岛素样生长因子I (hIGF-I) # 8917使用浓度逐渐增加的hHis6IGFBP3处理10分钟或不经过处理,然后裂解,使用PathScan® Phospho-Akt1 (Ser473) Sandwich ELISA Kit #7160测定Akt1 (Ser473)磷酸化水平。

Coomassie Gel

Coomassie Gel

The purity of recombinant hHis6IGFBP3 was determined by SDS-PAGE of 6 µg reduced (+) and non-reduced (-) recombinant.

SDS-PAGE测定6 µg还原(+)或不还原(-)的重组hHis6IGFBP3的纯度。


Optimal concentration for the desired application should be determined by the user.



Less than 0.01 ng endotoxin/1 μg hHis6IGFBP3.

1 μg hHis6IGFBP3中内毒素低于0.01 ng。


With carrier: Lyophilized from a 0.22 μm filtered solution of hHis6IGFBP3 in 20 mM Tris, pH 7.2 containing 20 μg BSA per 1 μg hHis6IGFBP3. Carrier free: Lyophilized from a 0.22 μm filtered solution of hHis6IGFBP3in 20 mM Tris, pH 7.2.

带载体:储存在含有 20 μg BSA 的20 mM Tris, pH 7.2 溶液中的1 μg hHHis6IGFBP3经过0.22 μm过滤后冻干。无载体:hHis6 IGFBP3 i在 20 mM Tris, pH 7.2经过0.22 μm过滤后冻干。


IGFBP3 is a multifunctional protein that plays a key role in regulation of IGFI/II activity, cell proliferation, and death. One of six high-affinity IGF binding proteins, IGFBP3 is the major species in circulation and is bound in a complex with ALS to 99% of hepatic IGF-I (1). Proteolytic degradation of IGFBP3 increases the bioavailability and activity of the IGF I/II (1). However, some biological activities of IGFBP3 are independent of the IGF/IGF-IR axis. IGFBP3 potentiates EGF-induced breast cancer cell proliferation in vitro by enhancing ERK phosphorylation and sphingosine kinase-mediated EGFR trans-activation (2,3). Conversely, IGFBP3 has been shown to induce apoptosis and inhibit NF-κB activity (4).

IGFBP3是一种多功能的蛋白,在调控IGFI/II活性,细胞增殖和细胞死亡上发挥关键作用。作为六个高亲和IGF结合蛋白之一,IGFBP3主要位于循环系统中,并和ALS结合成为复合物后与99%肝脏中的IGF- I结合 (1)。IGFBP3的蛋白降解过程增加了IGF I/II的生物活性(1)。但是,IGFBP3的某些生物性能是不依赖于IGF/IGF-IR信号通路的。体外实验表明IGFBP3通过增强ERK的磷酸化和sphingosine激酶介导的EGFR转化,从而增加可能引起了EGF诱发的乳腺癌(2,3)。相反的是,IGFBP3也被证明可以诱导凋亡并抑制NF-κB活性(4)。

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!

Companion Products

For Research Use Only. Not For Use In Diagnostic Procedures.

Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.

PathScan is a trademark of Cell Signaling Technology, Inc.

Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.

用户评论 --- 共 0


我要参与评论 :